Enbrel
® (
etanercept) is a prescription medication that is approved to treat several inflammatory conditions that affect the joints and skin.
Enbrel is made by Amgen.
Specific uses of Enbrel include reducing the signs and symptoms of the following conditions:
Enbrel has also been shown to decrease the damage caused by rhuematoid
arthritis and psoriatic arthrits. Enbrel is not a cure for rheumatoid arthritis or any of the other conditions mentioned above.
(Click Enbrel Uses for more information what Enbrel is used for, including possible off-label uses.)
Enbrel is part of a class of medicines known as tumor necrosis factor inhibitors, or TNF inhibitors for short. As the name of the drug class implies, Enbrel blocks the activity of tumor necrosis factor-alpha (TNF-alpha). TNF-alpha is a naturally occurring chemical in the body that is involved in inflammation and other immune system functions.
People with rheumatoid arthritis, psoriasis, or ankylosing spondylitis often have higher levels of TNF. These high levels of TNF-alpha can cause inflammation and lead to problems such as swollen, painful joints and raised, thick, red, scaly patches. By blocking TNF-alpha, Enbrel helps to keep the immune system from attacking the body, which improves symptoms and, in some cases, prevents future damage from occurring.